CN101336990A - Medicine for treating cholecystitis - Google Patents

Medicine for treating cholecystitis Download PDF

Info

Publication number
CN101336990A
CN101336990A CNA2008101387980A CN200810138798A CN101336990A CN 101336990 A CN101336990 A CN 101336990A CN A2008101387980 A CNA2008101387980 A CN A2008101387980A CN 200810138798 A CN200810138798 A CN 200810138798A CN 101336990 A CN101336990 A CN 101336990A
Authority
CN
China
Prior art keywords
parts
grams
medicament
radix
medicine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CNA2008101387980A
Other languages
Chinese (zh)
Other versions
CN101336990B (en
Inventor
李翠华
胡敏
杨彦伟
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN2008101387980A priority Critical patent/CN101336990B/en
Publication of CN101336990A publication Critical patent/CN101336990A/en
Application granted granted Critical
Publication of CN101336990B publication Critical patent/CN101336990B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The invention provides a medicament for curing cholecystitis, which is characterized in that the medicament comprises the following materials by the weight part: 20 to 29 parts of ant, 10 to 12 parts of fructus mume, 5 to 8 parts of raspberry, 10 to 12 parts of asiatic cornelian cherry fruit, 8 to 14 parts of lotus seed, 46 to 50 parts of bupleurum root, 46 to 50 parts of angelica root, 46 to 50 parts of radix gentianae, 46 to 50 parts of aucklandia root, 26 to 30 parts of rhubarb, 21 to 26 parts of amoorcorn tree bark and 31 to 40 parts of dandelion. The medicament has the advantages of good curative effect, rapid effect, convenient administration, recurrence prevention, convenience, low price, convenient preservation, carrying and administration, high efficacy, low dosage, little toxic or side effect, controllable quality and high stability, and has the curative effects of effectively removing coldness, regulating vital energy, invigorating stomach, promoting digestion, cholagogue and relieving internal heat or fever, and has the effects of cholagogue, anti-inflammation, fever relief, pain relief and bacteriostasis, moreover, the composition is a sugar-free traditional Chinese medicine composition which can be accepted by the diabetics, therefore, the medicament has wide market prospect.

Description

A kind of medicine for the treatment of cholecystitis
(1) technical field
The present invention relates to Chinese medicine composition, particularly a kind of medicine for the treatment of cholecystitis.
(2) background technology
At present, the medicine of treatment acute and chronic cholecystitis is more, has become the medicine commonly used of treatment gallbladder disease as medicines such as XIAOYAN LIDAN PIAN, DANTONG.The present defective of this class medicine mainly is to take for a long time, some toxic and side effects that the impairing the liver of being impairment of the kidney is arranged, gallbladder disease is very fast after the drug withdrawal can recur again, and mainly contain the pharmaceutical compositions of heat clearing away, detoxifcation dehumidifying, function of gallbladder promoting in the medicine of treatment gallbladder disease, take for a long time, also can cause cold syndrome of the stomach, cause diarrhoea in humans.
(3) summary of the invention
The present invention is in order to remedy the deficiencies in the prior art, provides that a kind of good effect, instant effect, easy to use, anti-recurrence, cold expelling are regulated the flow of vital energy, the medicine of invigorating the stomach and promoting digestion, function of gallbladder promoting antidotal treatment cholecystitis.
The present invention is achieved through the following technical solutions:
The medicine of treatment cholecystitis of the present invention, its special character is: the raw material by following parts by weight is formed: Formica fusca 20-29, Fructus Mume 10-12, Fructus Rubi 5-8, Fructus Corni 10-12, Semen Nelumbinis 8-14, Radix Bupleuri 46-50, Radix Angelicae Sinensis 46-50, Radix Gentianae 46-50, Radix Aucklandiae 46-50, Radix Et Rhizoma Rhei 26-30, Cortex Phellodendri 21-26, Herba Taraxaci 31-40.
Preparation method: raw material is added water soaked 30 minutes for 900 parts, be placed in the earth pot and boil, continue 30-40 minute, medical filtration is come out, filtering residue is added 900 parts in water, be placed in the earth pot and boil, continue 30-40 minute, medical filtration is come out, behind twice medicinal liquid mix homogeneously, be equally divided into two parts.
Therapeutic Method: every day, each once took portion at every turn sooner or later, and taking two parts every day is potion, and taking seven days is a course of treatment, and cure five courses of treatment.
The invention has the beneficial effects as follows good effect, instant effect, easy to use, anti-recurrence, easy cheapness, effectively cold expelling is regulated the flow of vital energy, invigorating the stomach and promoting digestion, function of gallbladder promoting detoxifcation, have good function of gallbladder promoting, antiinflammatory, analgesic, analgesia and bacteriostasis, preserve, carry, taking convenience, the curative effect height, dose is little, toxic and side effects is low, and is quality controllable, good stability, and be the Sugarless type Chinese medicine composition, can be accepted by the patient of vast double trouble diabetes, thereby its broad market prospect.
(4) specific embodiment
Embodiment 1
The medicine of treatment cholecystitis of the present invention is made up of the raw material of following weight: Formica fusca 25 grams, Fructus Mume 11 grams, Fructus Rubi 6.5 grams, Fructus Corni 11 grams, Semen Nelumbinis 11 grams, Radix Bupleuri 48 grams, Radix Angelicae Sinensis 48 grams, Radix Gentianae 48 grams, the Radix Aucklandiae 48 grams, Radix Et Rhizoma Rhei 28 grams, Cortex Phellodendri 24 grams, Herba Taraxaci 35 grams.
Preparation method: raw material is added water 900 grams soaked 30 minutes, be placed in the earth pot and boil, continue 30-40 minute, medical filtration is come out, filtering residue is added water 900 grams, be placed in the earth pot and boil, continue 30-40 minute, medical filtration is come out, behind twice medicinal liquid mix homogeneously, be equally divided into two parts.
Therapeutic Method: every day, each once took portion at every turn sooner or later, and taking two parts every day is potion, and taking seven days is a course of treatment, and cure five courses of treatment.
Embodiment 2
The medicine of treatment cholecystitis of the present invention is made up of the raw material of following weight: Formica fusca 20 grams, Fructus Mume 10 grams, Fructus Rubi 5 grams, Fructus Corni 10 grams, Semen Nelumbinis 8 grams, Radix Bupleuri 46 grams, Radix Angelicae Sinensis 46 grams, Radix Gentianae 46 grams, the Radix Aucklandiae 46 grams, Radix Et Rhizoma Rhei 26 grams, Cortex Phellodendri 21 grams, Herba Taraxaci 31 grams.
All the other are identical with embodiment 1.
Embodiment 3
The medicine of treatment cholecystitis of the present invention is made up of the raw material of following weight: Formica fusca 29 grams, Fructus Mume 12 grams, Fructus Rubi 8 grams, Fructus Corni 12 grams, Semen Nelumbinis 14 grams, Radix Bupleuri 50 grams, Radix Angelicae Sinensis 50 grams, Radix Gentianae 50 grams, the Radix Aucklandiae 50 grams, Radix Et Rhizoma Rhei 30 grams, Cortex Phellodendri 26 grams, Herba Taraxaci 40 grams.
All the other are identical with embodiment 1.
Data is summed up in embodiment 4 clinical researches
The present invention is through carrying out clinical observation treatment to 300 routine patients, male's 155 examples wherein, and women's 145 examples, the age 18 was cholecystitis to 70 years old.
(1) Therapeutic Method:
Every day, each once took portion at every turn sooner or later, and taking two parts every day is potion, and taking seven days is a course of treatment, and cure five courses of treatment.
(2) efficacy assessment standard:
Cure: sings and symptoms complete obiteration, functional activity recover normal.
Produce effects: the basic or big portion of clinical symptoms sign disappears.
Effectively: clinical symptoms is clearly better or takes a turn for the better.
Invalid: the clinical symptoms sign does not have improvement.
(3) therapeutic effect:
Clinical cure 282 examples account for 94%; Produce effects 12 examples account for 4%; Effective 6 examples account for 2%; Invalid 0 example; Total effective rate 100%.

Claims (1)

1.-plant the medicine of treatment cholecystitis, it is characterized in that: the raw material by following parts by weight is formed: Formica fusca 20-29, Fructus Mume 10-12, Fructus Rubi 5-8, Fructus Corni 10-12, Semen Nelumbinis 8-14, Radix Bupleuri 46-50, Radix Angelicae Sinensis 46-50, Radix Gentianae 46-50, Radix Aucklandiae 46-50, Radix Et Rhizoma Rhei 26-30, Cortex Phellodendri 21-26, Herba Taraxaci 31-40.
CN2008101387980A 2008-08-11 2008-08-11 Medicine for treating cholecystitis Expired - Fee Related CN101336990B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN2008101387980A CN101336990B (en) 2008-08-11 2008-08-11 Medicine for treating cholecystitis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN2008101387980A CN101336990B (en) 2008-08-11 2008-08-11 Medicine for treating cholecystitis

Publications (2)

Publication Number Publication Date
CN101336990A true CN101336990A (en) 2009-01-07
CN101336990B CN101336990B (en) 2010-12-01

Family

ID=40211255

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2008101387980A Expired - Fee Related CN101336990B (en) 2008-08-11 2008-08-11 Medicine for treating cholecystitis

Country Status (1)

Country Link
CN (1) CN101336990B (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102319390A (en) * 2011-09-30 2012-01-18 袁显海 The medicine of treatment chronic cholecystitis
CN105560916A (en) * 2014-10-08 2016-05-11 李俊平 Cholecystitis treating drug and preparation method thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1358512A (en) * 2000-12-12 2002-07-17 刘治国 Gallbladder normalizing soup
CN1267118C (en) * 2003-10-22 2006-08-02 赵炳君 Medicine for treating cholecystitis, and its prepn. method

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102319390A (en) * 2011-09-30 2012-01-18 袁显海 The medicine of treatment chronic cholecystitis
CN105560916A (en) * 2014-10-08 2016-05-11 李俊平 Cholecystitis treating drug and preparation method thereof

Also Published As

Publication number Publication date
CN101336990B (en) 2010-12-01

Similar Documents

Publication Publication Date Title
CN101336990B (en) Medicine for treating cholecystitis
CN101112475A (en) Chinese traditional medicine composition for treating diabetes and the complication
CN102988892B (en) Medicament for treating hysteromyoma and ovarian cysts
CN104857366A (en) Preoperative intervention medicine composition for neurosurgery and application thereof
CN102106999B (en) A kind of compound Chinese medicinal preparation for the treatment of dysphagia after apoplexy and preparation method thereof
CN104107264A (en) Traditional Chinese medicine agent for treating infantile constipation and preparation method and application of traditional Chinese medicine agent
CN101337062B (en) Traditional Chinese medicine composition for treating tonsillitis
CN101327293A (en) Capsules for treating peptic ulcer and preparation method thereof
CN102319390B (en) Medicament for treating chronic cholecystitis
CN110384785A (en) A kind of external application Chinese medicine medical fluid and preparation method thereof for treating virus flu
CN101259196B (en) Chinese medicinal composition for treating gastric ulcer
CN102274362B (en) Plaster for treating mastopathy and preparation method thereof
CN101904962B (en) Medicament for treating cold and preparation method thereof
CN100345567C (en) Medicine for treating functional headache
CN101502597A (en) Medicament for treating stomachache and preparation method thereof
CN105833094A (en) Traditional Chinese medicine composition for treating trachoma
CN104666824A (en) Traditional Chinese medicinal composition for treating psoriasis
CN104306663A (en) Traditional Chinese medicine composition for subsidiarily treating diabetes
CN104547865A (en) Application of traditional Chinese medicine preparation in preparing medicine for treating senile dementia
CN103463524B (en) Traditional Chinese medicine composition for treating osteomyelitis and preparation method thereof
CN102670875B (en) Traditional Chinese medicinal composition for treating gastric ulcer
CN102961722B (en) Traditional Chinese medicine composition for treating senile constipation
CN101897926A (en) Medicament for treating cholecystitis
CN114533847A (en) A Chinese medicinal patch for adjuvant treatment of pulmonary diseases
CN101181367A (en) Chinese medicine for curing menorrhalgia

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C53 Correction of patent for invention or patent application
CB03 Change of inventor or designer information

Inventor after: Ding Yinlu

Inventor after: Li Jin

Inventor after: Li Cuihua

Inventor after: Hu Min

Inventor after: Yang Yanwei

Inventor before: Ding Yinlu

Inventor before: Li Cuihua

Inventor before: Hu Min

Inventor before: Yang Yanwei

COR Change of bibliographic data

Free format text: CORRECT: INVENTOR; FROM: DING YINLU LI CUIHUA HU MIN YANG YANWEI TO: DING YINLU LI JIN LI CUIHUA HUMIN YANG YANWEI

C14 Grant of patent or utility model
GR01 Patent grant
C17 Cessation of patent right
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20101201

Termination date: 20110811